Dr Adam Brentnall is a statistician at the Centre for Cancer Prevention, Queen Mary University of London. Much of his research is focused on statistical modelling of cancer risk and related strategies for early detection and prevention. Methodological interests include standardization, accounting for unplanned crossover in clinical trials, and measures of model performance.
Dr Brentnall's research at Turing will include investigating ways to provide a better comprehensive cancer risk assessment than current models, by building on collaborative work in the area. Improvements are likely involve combining information from genetic factors, imaging, biomarkers and other risk factors. A major interest is to assess the potential for Artificial Intelligence or other algorithmic methods to improve risk assessment, particularly using imaging data. Methodological work to help better understand evidence supporting risk predictions or new treatments will also be undertaken.